135 related articles for article (PubMed ID: 2969986)
21. [Evaluation of a latex agglutination assay method for the determination of plasmin/alpha 2 plasmin inhibitor complex].
Murakami F; Iijima K; Nakamura K; Ikawa S
Rinsho Byori; 1994 Jun; 42(6):643-7. PubMed ID: 8051804
[TBL] [Abstract][Full Text] [Related]
22. [Reactions of alpha 2 plasmin inhibitor to plasmin and fibrin; its significance in fibrinolysis inhibition and hemostasis].
Ichinose A; Sakata Y; Aoki N
Rinsho Byori; 1982 Jun; Suppl 50():178-88. PubMed ID: 6215510
[No Abstract] [Full Text] [Related]
23. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
24. Alpha 2-plasmin inhibitor-plasmin complexes in synovial fluid.
Inman RD; Harpel PC
J Rheumatol; 1986 Jun; 13(3):535-7. PubMed ID: 2942685
[TBL] [Abstract][Full Text] [Related]
25. [t-PA-PAI-1 complex].
Maruyama I
Nihon Rinsho; 1999 Sep; 57 Suppl():688-90. PubMed ID: 10543214
[No Abstract] [Full Text] [Related]
26. Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes.
Brower MS; Harpel PC
Blood; 1983 May; 61(5):842-9. PubMed ID: 6219725
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of antithrombin III, plasminogen and alpha 2-plasmin inhibitor in perinatal period.
Fuse Y; Fuse K
Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):121-5. PubMed ID: 3160323
[No Abstract] [Full Text] [Related]
28. Enzyme immunoassay of alpha 2-plasmin inhibitor.
Takase T; Yoshikawa N; Okamoto H; Yasui M; Fujimura Y; Fukui H; Kato K
Nihon Ketsueki Gakkai Zasshi; 1984 Feb; 47(1):158-63. PubMed ID: 6377791
[No Abstract] [Full Text] [Related]
29. Evaluation of fibrinolytic therapy by measuring cross-linked fibrin derivatives and plasmin-alpha 2-plasmin inhibitor complex in plasma.
Takahashi H; Takizawa S; Hanano M; Tatewaki W; Nagasaki Y; Sasagawa Y; Shibata A
Tohoku J Exp Med; 1987 Dec; 153(4):295-302. PubMed ID: 2964745
[TBL] [Abstract][Full Text] [Related]
30. Significance of glomerular deposition of plasmin-alpha 2-plasmin inhibitor complexes in various glomerulopathies.
Suzuki S; Sato H; Shimada H; Takashima N; Kishimoto H; Ueno M; Nishi S; Wada K; Takahashi H; Shibata A
Clin Nephrol; 1993 Nov; 40(5):270-6. PubMed ID: 7506640
[TBL] [Abstract][Full Text] [Related]
31. [Hepatocyte receptors for proteinase inhibitor complexes with plasmin].
Zorin NA; Zhabin SG; Gorin VS
Tsitologiia; 1993; 35(2):55-9. PubMed ID: 7686697
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina.
Bayés-Genís A; Guindo J; Oliver A; Badimon L; Fiol M; Mateo J; Souto JC; Dominguez JM; Fontcuberta J; Bayés de Luna A
Thromb Haemost; 1999 Jun; 81(6):865-8. PubMed ID: 10404758
[TBL] [Abstract][Full Text] [Related]
33. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
[TBL] [Abstract][Full Text] [Related]
34. Plasmin inhibitors and fibrinogen breakdown during the initial phase of thrombolytic treatment--the problem of the alpha 2-antiplasmin determination.
Noll G; Lämmle B; Duckert F
Thromb Haemost; 1984 Jul; 51(3):334-7. PubMed ID: 6238441
[TBL] [Abstract][Full Text] [Related]
35. Plasmin--alpha 2-antiplasmin complex as an indicator of in vivo fibrinolysis.
Booth NA; Bennett B
Br J Haematol; 1982 Mar; 50(3):537-41. PubMed ID: 6461348
[TBL] [Abstract][Full Text] [Related]
36. Fibrinolysis in patients with diabetic nephropathy determined by plasmin-alpha 2 plasmin inhibitor complexes in plasma.
Yagame M; Eguchi K; Suzuki D; Machimura H; Takeda H; Inoue W; Tanaka K; Kaneshige H; Nomoto Y; Sakai H
J Diabet Complications; 1990; 4(4):175-8. PubMed ID: 2151230
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of alpha 2-plasmin inhibitor analysis in blood coagulation and fibrinolysis tests].
Hayashi T; Suzuki K
Nihon Rinsho; 1989 Dec; 48 Suppl():869-71. PubMed ID: 2516162
[No Abstract] [Full Text] [Related]
38. Mediators of fibrinolysis in orthotopic liver transplantation.
Cheema SP; Webster NR; Dunn F; Bellamy MC
Clin Transplant; 1996 Feb; 10(1 Pt 1):24-7. PubMed ID: 8652893
[TBL] [Abstract][Full Text] [Related]
39. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
40. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
